Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)

CUSIP: 09627Y109

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
65,000,000
Total 13F shares
67,115,861
Share change
+1,479,891
Total reported value
$5,854,192,362
Put/Call ratio
87%
Price per share
$87.22
Number of holders
336
Value change
+$126,899,926
Number of buys
187
Number of sells
124

Quarterly Holders Quick Answers

What is CUSIP 09627Y109?
CUSIP 09627Y109 identifies BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q4 2024

As of 31 Dec 2024, Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) was held by 336 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 67,115,861 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, FMR LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, MACQUARIE GROUP LTD, and Avoro Capital Advisors LLC. This page lists 337 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.